Suchergebnisse - "Camporota, Luigi"

PubPharm (16)

1

Year in review 2008: Critical Care - cardiology

enthalten in: Critical care | 2009

von Camporota, L. | Terblanche, M. | Bennett, D.

2

Year in review 2008: Critical Care - cardiology

enthalten in: Critical care | 2009

von Camporota, L. | Terblanche, M. | Bennett, D.

3

Year in review 2008 : Critical Care--cardiology

enthalten in: Critical care (London, England) | 2009

von Camporota, L. | Terblanche, M. | Bennett, D.

4

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy

enthalten in: Critical care | 2008

von Camporota, L. | Corno, E. | Menaldo, E. | +4

5

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy

enthalten in: Critical care | 2008

von Camporota, L. | Corno, E. | Menaldo, E. | +4

6

Year in review 2007: Critical Care – cardiology

enthalten in: Critical care | 2008

von Camporota, L. | Terblanche, M. | Bennett, D.

7

Year in review 2007: Critical Care – cardiology

enthalten in: Critical care | 2008

von Camporota, L. | Terblanche, M. | Bennett, D.

8

Year in review 2007 : Critical Care--cardiology

enthalten in: Critical care (London, England) | 2008

von Camporota, L. | Terblanche, M. | Bennett, D.

9

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy

enthalten in: Critical care (London, England) | 2008

von Camporota, L. | Corno, E. | Menaldo, E. | +4

CommentIn: Crit Care. 2009;13(1):113. - PMID 19226446

10

Practical aspects of treatment with drotrecogin alfa (activated)

enthalten in: Critical care | 2007

von Camporota, L. | Wyncoll, D.